Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Millan

Showing results (141-150 of 496) with videos related to

Pageof 50
Sort By:
Life Sciences|October 18, 1982
Naloxone attenuates the anxiolytic action of diazepam in manT Duka, M J Millan, B Ulsamer, et al.
Clinical Nephrology|November 1, 1980
Glomerulonephritis and Staphylococcal aureus infectionsD A Spector, J Millan, N Zauber, et al.
Experimental Neurology|July 4, 2006
Actions at sites other than D(3) receptors mediate the effects of BP897 on l-DOPA-induced hyperactivity in monoamine-depleted ratsNaomi P Visanji, Mark J Millan, Jonathan M Brotchie
Revista De Neurologia|July 2, 2008
[Statins and neuromuscular pathology]L Turpin-Fenoll, J Millan-Pascual, C Martin-Estefania
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 17, 2009
Differential influence of selective 5-HT5A vs 5-HT1A, 5-HT1B, or 5-HT2C receptor blockade upon light-induced phase shifts in circadian activity rhythms: interaction studies with citalopramRobert L Gannon, Jean-Louis Peglion, Mark J Millan
Acta Leprologica|October 1, 1986
[Practical problems encountered in the multi-drug therapy of leprosy in Senegal]J C Naudin, G Detoeuf, B Diouf, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 7, 2014
Effects of systemically applied nAChRα7 agonists and antagonists on light-induced phase shifts of hamster circadian activity rhythmsRobert L Gannon, David A Garcia, Mark J Millan
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 3, 2014
Novel dimensions of D3 receptor function: Focus on heterodimerisation, transactivation and allosteric modulationRoberto Maggio, Marco Scarselli, Marta Capannolo, et al.
Pain|May 1, 1995
Antinociceptive profiles of non-peptidergic neurokinin1 and neurokinin2 receptor antagonists: a comparison to other classes of antinociceptive agentL Seguin, S Le Marouille-Girardon, M J Millan
Neuropharmacology|March 23, 2000
Discriminative stimulus properties of the dopamine D3 receptor agonists, PD128,907 and 7-OH-DPAT: a comparative characterization with novel ligands at D3 versus D2 receptorsM J Millan, S Girardon, S Monneyron, et al.
Pageof 50

Showing results (141-150 of 496) with videos related to

Sort By:
Pageof 50
Life Sciences|October 18, 1982
Naloxone attenuates the anxiolytic action of diazepam in manT Duka, M J Millan, B Ulsamer, et al.
Clinical Nephrology|November 1, 1980
Glomerulonephritis and Staphylococcal aureus infectionsD A Spector, J Millan, N Zauber, et al.
Experimental Neurology|July 4, 2006
Actions at sites other than D(3) receptors mediate the effects of BP897 on l-DOPA-induced hyperactivity in monoamine-depleted ratsNaomi P Visanji, Mark J Millan, Jonathan M Brotchie
Revista De Neurologia|July 2, 2008
[Statins and neuromuscular pathology]L Turpin-Fenoll, J Millan-Pascual, C Martin-Estefania
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 17, 2009
Differential influence of selective 5-HT5A vs 5-HT1A, 5-HT1B, or 5-HT2C receptor blockade upon light-induced phase shifts in circadian activity rhythms: interaction studies with citalopramRobert L Gannon, Jean-Louis Peglion, Mark J Millan
Acta Leprologica|October 1, 1986
[Practical problems encountered in the multi-drug therapy of leprosy in Senegal]J C Naudin, G Detoeuf, B Diouf, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 7, 2014
Effects of systemically applied nAChRα7 agonists and antagonists on light-induced phase shifts of hamster circadian activity rhythmsRobert L Gannon, David A Garcia, Mark J Millan
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 3, 2014
Novel dimensions of D3 receptor function: Focus on heterodimerisation, transactivation and allosteric modulationRoberto Maggio, Marco Scarselli, Marta Capannolo, et al.
Pain|May 1, 1995
Antinociceptive profiles of non-peptidergic neurokinin1 and neurokinin2 receptor antagonists: a comparison to other classes of antinociceptive agentL Seguin, S Le Marouille-Girardon, M J Millan
Neuropharmacology|March 23, 2000
Discriminative stimulus properties of the dopamine D3 receptor agonists, PD128,907 and 7-OH-DPAT: a comparative characterization with novel ligands at D3 versus D2 receptorsM J Millan, S Girardon, S Monneyron, et al.
Pageof 50